SEC Filing Summary: Bioflamex Corporation (Form 8-K)
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Bioflamex Corporation on June 21, 2012. The registrant is incorporated in Nevada with principal executive offices in Charlottenlund, Denmark. The filing addresses a material accounting issue requiring the restatement of previously issued financial statements.
Financial Metrics
The filing does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The document explicitly states that management has not yet determined the quantitative impact of the identified errors on the Company's financial condition, results of operations, or cash flows for prior periods.
Material Changes and Restatement
The Board of Directors determined that the Company's Annual Report on Form 10-K for the year ended February 28, 2011, and Quarterly Reports on Form 10-Q for the periods ended May 31, 2011, August 31, 2011, and November 30, 2011, contain errors and should not be relied upon. The errors relate to:
- Certain liabilities that were not previously disclosed.
- Corresponding expenses incurred.
- Material agreements executed during the fiscal years ended February 29, 2012, and February 28, 2011.
The Company intends to amend the aforementioned reports to correct these errors in accordance with FASB ASC Topic 250.
Outlook, Risks, and Management Commentary
Management has discussed the matter with the independent registered public accounting firm, Weaver, Martin & Samyn, LLC. The Company expects to file the amended Form 10-K and Form 10-Q reports by July 20, 2012, or a date soon thereafter. Until the restatement is complete, the financial condition and results of operations disclosed in prior periods cannot be relied upon.
Key Facts for Investor Verification
- Verify the filing of amended Form 10-K (year ended Feb 28, 2011) and Form 10-Qs (periods ended May, Aug, and Nov 2011) by the expected date of July 20, 2012.
- Review the restated financial statements to determine the specific impact of undisclosed liabilities and expenses on historical profitability and liquidity.
- Confirm the nature of the "material agreements" that were previously undisclosed.
- Monitor for any further disclosures regarding the scope of the accounting errors or potential regulatory inquiries.